Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 35 out of 100. Mild cognitive impairment

Topic: Amyloid, tau and blood-test diagnosis

Objectives Oxidative stress plays a key role in the progression of chronic disorders including Alzheimer’s disease (AD) and mild cognitive impairment (MCI). This study aimed to assess oxidative stress in MCI and AD patients using ischemia-modified albumin (IMA) and dynamic thiol – disulfide homeostasis (TDH), and to investigate their potential as prognostic biomarkers.Methods A total of 128 participants were included in this study: 44 with normal cognition, 44 with MCI, and 40 with AD. All patients were evaluated based on mental status, comorbidities, and laboratory parameters. Serum levels of native thiol, total thiol, disulfide bonds, and IMA were measured.Result Native and total thiol levels were significantly lower in late-stage AD patients compared to controls (p ≤ 0.05). Furthermore, thiol levels were also significantly lower in the combined middle- and late-stage AD group compared to controls (p ≤ 0.05). Although thiol levels in MCI patients were lower than in controls and higher than in AD, the differences were not statistically significant. Thiol levels positively correlated with MMSE scores (p ≤ 0.05) and showed a marked decline with advancing age (p < 0.001). Hypertensive patients also had significantly lower thiol levels compared to those without hypertension (p < 0.05).Conclusion Our findings suggest that total and native thiol levels decline with cognitive deterioration and advancing age. These oxidative stress biomarkers might hold potential as supportive tools in the prognostic assessment of patients, particularly those with Alzheimer’s disease.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Altıntop, S. E., Yurt, E. F., Ayçiçek, G. Ş., Neşeli̇oğlu, S., Erel, Ö., Doğu, B. B., et al. (2025). Evaluation of oxidative stress biomarkers in mild cognitive impairment and Alzheimer’s disease: targeting dynamic thiol–disulfide homeostasis and ischemia-modified albumin. Neurological Research. https://doi.org/10.1080/01616412.2025.2551865

Vancouver

Altıntop SE, Yurt EF, Ayçiçek GŞ, Neşeli̇oğlu S, Erel Ö, Doğu BB, et al. Evaluation of oxidative stress biomarkers in mild cognitive impairment and Alzheimer’s disease: targeting dynamic thiol–disulfide homeostasis and ischemia-modified albumin. Neurological Research. 2025. doi:10.1080/01616412.2025.2551865. PMID: 40859599.

BibTeX

@article{altntop2025-40859599,
  author  = {Altıntop, Sabri Engin and Yurt, Emine Feyza and Ayçiçek, Gözde Şengül and Neşeli̇oğlu, Salim and Erel, Özcan and Doğu, Burcu Balam and Cankurtaran, Mustafa and Halil, Meltem Gulhan},
  title   = {{Evaluation of oxidative stress biomarkers in mild cognitive impairment and Alzheimer’s disease: targeting dynamic thiol–disulfide homeostasis and ischemia-modified albumin}},
  journal = {Neurological Research},
  year    = {2025},
  doi     = {10.1080/01616412.2025.2551865},
  pmid    = {40859599},
  url     = {https://doi.org/10.1080/01616412.2025.2551865}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that native and total thiol levels were significantly lower in late-stage Alzheimer's disease patients than controls, but the differences in mild cognitive impairment patients were not statistically significant. It does not test a treatment or cure, and it only suggests these oxidative stress markers may be useful for monitoring cognitive deterioration.

Study details

How this study scored 35/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 0 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 35 of 100.35 of 100 points earned65 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neurological Research)
Journal's citation record 1 / 4 Neurological Research: journal h-index 108 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 128 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Meltem Gulhan Halil: h-index 38 (OpenAlex, whole career)
Institution's track record 0 / 3 Hacettepe University: institution h-index 410 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40859599)
Free to read 0 / 2 Behind a paywall — scores zero
Total 35 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Mild cognitive impairment

Also tagged “cerebrospinal”

821 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 821 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Mild cognitive impairment

See all studies in Mild cognitive impairment →